Li Chenyan, Peng Shiqiao, Liu Xin, Han Cheng, Wang Xinyi, Jin Ting, Liu Shanshan, Wang Weiwei, Xie Xiaochen, He Xue, Zhang Hanyi, Shan Ling, Fan Chenling, Shan Zhongyan, Teng Weiping
1 Department of Endocrinology and Metabolism, Institute of Endocrinology, Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Affiliated Hospital of China Medical University, China Medical University , Shenyang, People's Republic of China .
2 Department of Intensive Care Unit, Affiliated Hospital of Qingdao University , Qingdao, People's Republic of China .
Thyroid. 2017 May;27(5):722-731. doi: 10.1089/thy.2016.0432.
High mobility group box-1 (HMGB1), a non-histone protein, plays an important role in autoimmune diseases. However, the significance of HMGB1 in the pathogenesis of autoimmune thyroiditis has not been reported. The purpose of this study was to explore whether HMGB1 participates in the pathogenesis of autoimmune thyroiditis, and whether glycyrrhizin (GL), a direct inhibitor of HMGB1, attenuates the severity of thyroid inflammatory infiltration in a murine model of autoimmune thyroiditis.
A total of 80 male NOD.H-2 mice were randomly divided into a control or iodine supplement (NaI) group at four weeks of age, and the control group was fed with regular water, whereas the NaI group was supplied with 0.005% sodium iodine water. Another 24 male NOD.H-2 mice were also randomized into three groups (eight mice per group) as follows: control, NaI, and GL treatment after iodine supplementation (NaI + GL). The NOD.H-2 mice were fed with 0.005% sodium iodide water for eight weeks to enhance autoimmune thyroiditis. After iodine treatment, the mice received intraperitoneal injections of GL for four weeks. The severity of lymphocytic infiltration in the thyroid gland was measured by histopathological studies. The serum levels of HMGB1, tumor necrosis factor alpha, interleukin (IL)-6, IL-1β, and thyroglobulin antibody titers were measured using an enzyme-linked immunosorbent assay. HMGB1 expression was measured by immunohistochemical staining and real-time polymerase chain reaction. TLR2, HMGB1, MyD88, and nuclear transcription factor κB were measured by Western blot.
The mRNA expression of HMGB1 was significantly higher at 8 and 16 weeks in the NaI group than it was in the control group. Serum levels of thyroglobulin antibodies, HMGB1, tumor necrosis factor alpha, IL-6, and IL-1β were significantly increased in the NaI group, but they were dramatically attenuated with GL injection. The prevalence of thyroiditis and the infiltration of lymphocytes were significantly decreased in the NaI + GL group. GL administration also significantly reduced the protein expression of TLR2, MyD88, HMGB1 and nuclear transcription factor κB in the thyroid gland and attenuated the severity of thyroiditis.
HMGB1 may play a crucial role in autoimmune thyroiditis by causing inflammatory infiltration, thus increasing the severity of autoimmune thyroiditis. GL effectively attenuated thyroiditis in the iodine-induced NOD.H-2 mice via a molecular mechanism related to the inhibition of TLR2-HMGB1 signaling.
高迁移率族蛋白B1(HMGB1)是一种非组蛋白,在自身免疫性疾病中起重要作用。然而,HMGB1在自身免疫性甲状腺炎发病机制中的意义尚未见报道。本研究旨在探讨HMGB1是否参与自身免疫性甲状腺炎的发病机制,以及HMGB1的直接抑制剂甘草酸(GL)是否能减轻自身免疫性甲状腺炎小鼠模型中甲状腺炎性浸润的严重程度。
80只雄性NOD.H-2小鼠在4周龄时随机分为对照组或碘补充(NaI)组,对照组给予普通水,而NaI组给予0.005%碘化钠水。另外24只雄性NOD.H-2小鼠也随机分为三组(每组8只),如下:对照组、NaI组和碘补充后GL治疗组(NaI + GL)。给NOD.H-2小鼠喂食0.005%碘化钠水8周以加重自身免疫性甲状腺炎。碘治疗后,小鼠腹腔注射GL 4周。通过组织病理学研究测量甲状腺中淋巴细胞浸润的严重程度。使用酶联免疫吸附测定法测量血清中HMGB1、肿瘤坏死因子α、白细胞介素(IL)-6、IL-1β和甲状腺球蛋白抗体滴度。通过免疫组织化学染色和实时聚合酶链反应测量HMGB1表达。通过蛋白质印迹法测量TLR2、HMGB1、MyD88和核转录因子κB。
NaI组在8周和16周时HMGB1的mRNA表达明显高于对照组。NaI组血清甲状腺球蛋白抗体、HMGB1、肿瘤坏死因子α、IL-6和IL-1β水平显著升高,但注射GL后显著降低。NaI + GL组甲状腺炎的患病率和淋巴细胞浸润明显降低。给予GL还显著降低了甲状腺中TLR2、MyD88、HMGB1和核转录因子κB的蛋白表达,并减轻了甲状腺炎的严重程度。
HMGB1可能通过引起炎性浸润在自身免疫性甲状腺炎中起关键作用,从而增加自身免疫性甲状腺炎的严重程度。GL通过与抑制TLR2-HMGB1信号传导相关的分子机制有效减轻碘诱导的NOD.H-2小鼠的甲状腺炎。